Enterovirus Infections  >>  GSK2878175  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK2878175 / GSK
NCT02014571: Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Completed
1
37
US
GSK2878175, Placebo
GlaxoSmithKline, PPD
Hepatitis C, Chronic
07/14
01/15

Download Options